Effect of tirzepatide on blood pressure levels in overweight/obese individuals without diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of tirzepatide on blood pressure levels in overweight/obese individuals without diabetes

Published:2023-12 Issue: Volume: Page:
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Patoulias Dimitrios^ORCID,Popovic Djordje S.,Koufakis Theocharis,Stavropoulos Konstantinos^ORCID,Doumas Michael

Publisher

Elsevier BV

Subject

Internal Medicine

Reference10 articles.

1. Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction;Nauck;Cardiovasc Diabetol,2022

2. Should tirzepatide be considered for early management in type 2 diabetes? Pros and cons;Koufakis;Expert Opin Pharmacother,2023

3. Efficacy and safety of tirzepatide in type 2 diabetes and obesity management;Sinha;J Obes Metab Syndr,2023

4. Tirzepatide decreases systolic and diastolic blood pressure;Copur;Eur J Intern Med,2023

5. Effect of tirzepatide on blood pressure and lipids: a meta-analysis of randomized controlled trials;Kanbay;Diabetes Obes Metab,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP